{
    "code": "70000035",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=70000035",
    "time": "2017-05-26 03:07:09",
    "許可證字號": "衛部罕藥輸字第000035號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "110\/08\/25",
    "發證日期": "105\/08\/25",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA07000003507",
    "中文品名": "柯珮鬆注射液40毫克",
    "英文品名": "Copaxone 40mg\/ml, Pre-Filled syringe for Injection",
    "適應症": "用於復發型多發性硬化症，以減少復發型多發性硬化症病人的復發頻率。",
    "劑型": "27D注射液劑",
    "包裝": "1ml注射針筒(附針) 100支以下盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "GLATIRAMERACETATE"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "620102K944  香港商艾維斯有限公司台灣分公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F240011100  TEVA PHARMACEUTICAL INDUSTRIES LTD.",
        "製造廠廠址": "18, ELI HURVITZ STREET, KFAR SABA 4410202, ISRAEL",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200043510",
            "成分名稱": "GLATIRAMER ACETATE",
            "含量描述": "",
            "含量": "40.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "020000350005_201609_Information for user-105-09-29.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=70000035&Seq=002&Type=9"
        },
        {
            "title": "020000350006_201609_Carton-105-09-29.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=70000035&Seq=003&Type=8"
        }
    ]
}